See more : Nixu Oyj (NIXU.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Ayujoy Herbals Ltd. (AJOY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ayujoy Herbals Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Gautam Exim Limited (GEL.BO) Income Statement Analysis – Financial Results
- Epsilon Healthcare Limited (HDRPF) Income Statement Analysis – Financial Results
- Sunrise Realty Trust, Inc. (SUNS) Income Statement Analysis – Financial Results
- The Crypto Company (CRCW) Income Statement Analysis – Financial Results
- Hunan Lead Power Dazhi Technology Incorporated Company (300530.SZ) Income Statement Analysis – Financial Results
Ayujoy Herbals Ltd. (AJOY)
About Ayujoy Herbals Ltd.
Ayujoy Herbals Ltd., a research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices. The company serves various pharmaceutical companies in India and Southeast Asia to get FDA approval and facilitate exports of pharmaceuticals, and medical products and devices to the United States. Its services include analytical QC, QA functions, readiness for inspections, compliance, validation, clinical trial management, regulatory/legal, preparation of regulatory filings, compliance assessments, risk assessments, mock FDA audits, medical device support, CMC support, GMP training, facility layout consulting, and training, as well as utilities, process, IT, computer, and cleaning validation services. The company was incorporated in 2008 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 189.14K | 0.00 | 55.97M | 55.87M | 75.91M | 70.87M | 65.19M | 56.43M | 44.57K |
| Cost of Revenue | 0.00 | 24.17K | 0.00 | 36.98M | 37.60M | 51.63M | 49.70M | 45.65M | 40.14M | 30.09K |
| Gross Profit | 0.00 | 164.98K | 0.00 | 18.99M | 18.26M | 24.28M | 21.17M | 19.54M | 16.29M | 14.48K |
| Gross Profit Ratio | 0.00% | 87.22% | 0.00% | 33.93% | 32.69% | 31.98% | 29.87% | 29.98% | 28.86% | 32.49% |
| Research & Development | 0.00 | 538.67K | 190.27K | 695.71K | 1.01M | 3.56M | 3.52M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.70K | 2.15K | 2.19K | 1.47K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.48K | 9.03K | 7.66K | 6.01K |
| SG&A | 65.14K | 293.58K | 234.96K | 10.64M | 10.03M | 13.05M | 12.17M | 11.19M | 9.85M | 7.48K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 65.14K | 832.25K | 425.23K | 11.33M | 11.04M | 16.61M | 15.69M | 11.19M | 9.85M | 9.26K |
| Cost & Expenses | 65.14K | 856.42K | 425.23K | 48.31M | 48.64M | 68.24M | 65.39M | 56.83M | 49.99M | 39.35K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 1.36K | 236.56K | 406.49K | 576.53K | 1.45M | 2.71M | 2.58M | 2.49M | 1.24K |
| EBITDA | -136.39K | -665.91K | -425.23K | 8.07M | 5.02M | 9.12M | 8.19M | 10.94M | 8.96M | 7.00M |
| EBITDA Ratio | 0.00% | -352.07% | 0.00% | 14.41% | 13.96% | 12.01% | 11.55% | 16.78% | 15.82% | 14.50% |
| Operating Income | -65.14K | -667.27K | -425.23K | 7.66M | 7.22M | 7.67M | 5.48M | 8.36M | 6.44M | 5.22K |
| Operating Income Ratio | 0.00% | -352.79% | 0.00% | 13.69% | 12.93% | 10.10% | 7.73% | 12.82% | 11.41% | 11.72% |
| Total Other Income/Expenses | -71.25K | -2.00 | 0.00 | 4.00 | -2.78M | -4.00 | 0.00 | -618.28K | -2.49M | 5.22M |
| Income Before Tax | -136.39K | -667.27K | -425.23K | 7.66M | 4.44M | 7.67M | 5.48M | 7.74M | 6.47M | 5.22K |
| Income Before Tax Ratio | 0.00% | -352.79% | 0.00% | 13.69% | 7.95% | 10.10% | 7.73% | 11.87% | 11.46% | 11.72% |
| Income Tax Expense | -167.90K | 2.00 | -236.56K | 1.27M | 1.17M | 1.22M | 863.40K | 1.24M | 1.02M | 805.57 |
| Net Income | -136.39K | -667.27K | -425.23K | 6.39M | 3.27M | 6.45M | 4.61M | 6.50M | 5.44M | 4.42K |
| Net Income Ratio | 0.00% | -352.79% | 0.00% | 11.42% | 5.86% | 8.50% | 6.51% | 9.97% | 9.64% | 9.91% |
| EPS | 0.00 | -0.01 | -0.01 | 0.14 | 0.07 | 0.14 | 0.10 | 0.14 | 0.12 | 0.09 |
| EPS Diluted | 0.00 | -0.01 | -0.01 | 0.14 | 0.07 | 0.14 | 0.10 | 0.14 | 0.12 | 0.09 |
| Weighted Avg Shares Out | 60.93M | 60.50M | 60.50M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14K |
| Weighted Avg Shares Out (Dil) | 60.93M | 60.50M | 60.50M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14M | 47.14K |
Interbrands Expands Its Diverse Portfolio with the Acquisition of Virginia-Based BEVINC
Ayujoy Herbals Ltd. Announces Strategic Developments, Welcomes New Leadership, and Engages AlphaBull for Enhanced Communication Strategies
Ayujoy Herbals Ltd. Announces Strategic Developments, Welcomes New Leadership, and Engages AlphaBull for Enhanced Communication Strategies
Source: https://incomestatements.info
Category: Stock Reports